D
Lantern Pharma Inc. LTRN
$3.75 -$0.18-4.58%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 9.15% 8.85% -29.98% -32.40% 33.39%
Total Depreciation and Amortization 3.46% 2.66% -72.53% 4,337.84% 5.71%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -968.18% -87.67% 180.82% -174.53% -30.89%
Change in Net Operating Assets -203.15% -114.15% 142.36% 212.69% -214.84%
Cash from Operations -7.55% -69.16% 9.36% 6.28% -0.56%
Capital Expenditure 30.23% -95.45% 56.86% -6.25% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 445.50% 64.30% -312.02% 10.49% 151.73%
Cash from Investing 436.62% 63.66% -317.10% 10.57% 150.68%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -100.00% 110.94% -- --
Foreign Exchange rate Adjustments 43.36% 215.31% -104.17% 60.66% -90.63%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 9.43% -50.33% 1.49% -7.12% 16.35%
Weiss Ratings